4/A: Cardio Diagnostics CEO Acquires Additional Shares

Meeshanthini Dogan, CEO of Cardio Diagnostics Holdings, Inc., purchased 68,965 shares of common stock at $0.29 per share on September 6, 2024, increasing her total holdings.

Summary

• Meeshanthini Dogan, the CEO of Cardio Diagnostics Holdings, Inc. (NUTX), reported a transaction involving the acquisition of the company's common stock.
• On September 6, 2024, Ms. Dogan purchased 68,965 shares at a price of $0.29 per share.
• Following this transaction, Ms. Dogan's total beneficial ownership amounts to 1,655,429 shares.
• The shares are held directly and jointly with her spouse, who is the issuer's Chief Technology Officer.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but without additional context, it's difficult to gauge the full impact.

Positives

• The CEO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. Monitoring these filings can offer insights into management's sentiment and potential future performance.

Key Dates